Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Black Diamond Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2017 · IPO 2020 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$38M
Market cap · Apr/2026
Revenue
$70M
Latest reported FY

Investors

7 investors on Black Diamond Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Versant Ventures
Series B+ 6 investors entered at this stage
BVF Partners
RA Capital Management
Tavistock Group
Boxer Capital
Wellington Management
NEA

Global footprint

Where Black Diamond Therapeutics has talent and traffic

Web traffic by country
3.8K monthly visits
across markets
🇺🇸 United States84.2%
🇮🇳 India10.5%
🇮🇹 Italy5.3%
Top 3 markets shown

See Black Diamond Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo